8. Malignant Disease and Immunosuppression


First line drugs Second line drugs Specialist drugs Secondary care drugs
Recommended in both primary and secondary care Alternatives (often in specific conditions) in both primary and secondary care Where a specialist input is needed (see introduction for definition) Prescribing principally within secondary care only

All drugs listed in this chapter should only be initiated under the supervision of a specialist

In the first instance refer to South West Strategic Clinical Network for Systemic Anti Cancer Therapy Protocols:

http://www.swscn.org.uk/guidance-protocols/cancer-protocols/

If the information your require is not available refer to Avon, Somerset and Wiltshire Cancer Services (ASWCS) chemotherapy guidelines for further information

      Solid tumours: http://www.avon.nhs.uk/aswcs-chemo/STCP/

      Haematology: http://www.avon.nhs.uk/aswcs-chemo/HCP/

Drugs that are approved for use under the Cancer drugs fund are considered on the formulary if used in within the criteria set by the fund.

 

For extravasation please see your local policy:

UHB

NBT

Last updated by: Emily Knight on 30-08-2017 09:58